ストックスクリーナーアプリを入手
1.1982
2.59%
-0.0318
前日終値:
$1.23
開ける：
$1.26
24時間の取引高:
193.67K
Relative Volume:
0.03
時価総額：
$6.87M
収益：
$14.64M
当期純損益:
$-13.74M
株価収益率:
-0.1648
EPS:
-7.27
ネットキャッシュフロー:
$-5.04M
1週間 パフォーマンス:
-1.79%
1か月 パフォーマンス:
-53.74%
6か月 パフォーマンス:
+126.12%
1年 パフォーマンス:
+92.33%
1日の値動き範囲:
$1.16
$1.275
1週間の範囲:
$1.1525
$1.38
52週間の値動き範囲:
$0.46
$4.44
Novabay Pharmaceuticals Inc Stock (NBY) Company Profile
名前
Novabay Pharmaceuticals Inc
セクター
電話
510-899-8800
住所
2000 Powell Street, Suite 1150, Emeryville, CA
NBY を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NBY
Novabay Pharmaceuticals Inc
|
1.18 | 7.39M | 14.64M | -13.74M | -5.04M | -7.27 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.12 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
472.79 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.45 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
801.26 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
331.58 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Novabay Pharmaceuticals Inc Stock (NBY) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2019-09-18 | 開始されました | Ladenburg Thalmann | Buy |
| 2018-07-06 | 繰り返されました | H.C. Wainwright | Buy |
| 2017-11-15 | 繰り返されました | Laidlaw | Buy |
| 2017-06-05 | 開始されました | ROTH Capital | Buy |
| 2017-03-27 | 開始されました | Laidlaw | Buy |
| 2017-02-06 | 開始されました | Rodman & Renshaw | Buy |
| 2016-03-07 | ダウングレード | Maxim Group | Buy → Hold |
| 2015-12-14 | 繰り返されました | Maxim Group | Buy |
| 2015-04-30 | 再開されました | Maxim Group | Buy |
| 2013-03-06 | 開始されました | Ascendiant Capital Markets | Strong Buy |
| 2008-01-03 | 開始されました | Dawson James | Speculative Buy |
すべてを表示
Novabay Pharmaceuticals Inc (NBY) 最新ニュース
Is NovaBay Pharmaceuticals Inc. reversing from oversold territory2025 Fundamental Recap & AI Driven Stock Price Forecasts - newser.com
Statistical indicators supporting NovaBay Pharmaceuticals Inc.’s strengthPortfolio Growth Summary & Fast Gaining Stock Reports - newser.com
Institutional scanner results for NovaBay Pharmaceuticals Inc.July 2025 WrapUp & Advanced Swing Trade Entry Plans - newser.com
What technical signals suggest for NovaBay Pharmaceuticals Inc. stockTrade Risk Report & Risk Adjusted Buy and Sell Alerts - newser.com
Custom strategy builders for tracking NovaBay Pharmaceuticals Inc.Trade Exit Summary & Safe Entry Zone Identification - newser.com
Can NovaBay Pharmaceuticals Inc. (B9P0) stock beat analyst consensusQuarterly Growth Report & Technical Pattern Recognition Alerts - newser.com
Can NovaBay Pharmaceuticals Inc. stock hit analyst price targetsTrade Risk Assessment & Weekly Stock Performance Updates - newser.com
What institutional flow reveals about NovaBay Pharmaceuticals Inc.Market Sentiment Summary & Weekly Momentum Stock Picks - newser.com
NovaBay Pharmaceuticals CEO David Lazar to resign following stock transfer agreement - Investing.com Canada
Visual analytics tools that track NovaBay Pharmaceuticals Inc. performance2025 Geopolitical Influence & Community Consensus Trade Signals - newser.com
Published on: 2025-10-09 05:27:34 - newser.com
Using flow based indicators on NovaBay Pharmaceuticals Inc.Weekly Earnings Recap & Daily Risk Controlled Trade Plans - newser.com
Reviewing AngioSoma (OTCMKTS:SOAN) and NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) - Defense World
NovaBay Pharmaceuticals Inc Stock Analysis and ForecastPrice Volatility Patterns & Budget Friendly Portfolio Growth - earlytimes.in
Why NovaBay Pharmaceuticals Inc. stock is popular among millennialsTrade Analysis Report & Verified Swing Trading Watchlists - newser.com
Will NovaBay Pharmaceuticals Inc. (B9P0) stock outperform small cap peersMarket Rally & Weekly Market Pulse Updates - newser.com
Is NovaBay Pharmaceuticals Inc. (B9P0) stock cheap by valuation metrics2025 AllTime Highs & Growth Focused Entry Reports - newser.com
How to read the order book for NovaBay Pharmaceuticals Inc.Weekly Volume Report & Weekly Market Pulse Updates - newser.com
What analysts say about NovaBay Pharmaceuticals Inc stockEarnings Miss Alerts & Low Cost Wealth Strategies - earlytimes.in
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
How NovaBay Pharmaceuticals Inc. (B9P0) stock reacts to monetary easingQuarterly Trade Review & High Accuracy Trade Alerts - newser.com
Novabay Pharmaceuticals Inc (NBY) 財務データ
収益
当期純利益
現金流量
EPS
Novabay Pharmaceuticals Inc (NBY) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| POPLAR POINT CAPITAL PARTNERS | 10% Owner |
Apr 04 '25 |
Buy |
0.52 |
4,538 |
2,367 |
1,020,000 |
| POPLAR POINT CAPITAL PARTNERS | 10% Owner |
Apr 02 '25 |
Buy |
0.58 |
917 |
532 |
992,486 |
| POPLAR POINT CAPITAL PARTNERS | 10% Owner |
Apr 08 '25 |
Buy |
0.47 |
300 |
140 |
1,020,300 |
| POPLAR POINT CAPITAL PARTNERS | 10% Owner |
Mar 28 '25 |
Buy |
0.61 |
49,400 |
30,253 |
950,000 |
| POPLAR POINT CAPITAL PARTNERS | 10% Owner |
Mar 31 '25 |
Buy |
0.59 |
21,654 |
12,776 |
971,654 |
| POPLAR POINT CAPITAL PARTNERS | 10% Owner |
Mar 27 '25 |
Buy |
0.61 |
19,104 |
11,745 |
900,600 |
| POPLAR POINT CAPITAL PARTNERS | 10% Owner |
Apr 01 '25 |
Buy |
0.58 |
19,915 |
11,650 |
991,569 |
| POPLAR POINT CAPITAL PARTNERS | 10% Owner |
Mar 26 '25 |
Buy |
0.61 |
13,292 |
8,095 |
881,496 |
| POPLAR POINT CAPITAL PARTNERS | 10% Owner |
Mar 25 '25 |
Buy |
0.61 |
22,635 |
13,807 |
868,204 |
| POPLAR POINT CAPITAL PARTNERS | 10% Owner |
Mar 18 '25 |
Buy |
0.63 |
14,000 |
8,820 |
832,277 |
1.19%
大文字化:
|
ボリューム (24 時間):